PM360 2022 Innovative Product KOL Select Video Engagement Platform from Bionical Solutions

KOL Select Video Engagement Platform

Bionical Solutions

Contact Person:
Mike Viscel, President

KOL Select is an innovative video engagement platform that delivers customized education in collaboration with their customers. Developed by Bionical Solutions, this award-winning platform strengthens relationships between field forces and their HCPs through deliverables that communicate safety, efficacy, patient identification, and optimal disease state management information. The KOL Select platform is designed to improve rep-HCP engagement—while delivering key insights within a memorable user experience.

KOL Select facilitates omnichannel connections between HCPs and brands with peer-to-peer messaging, a resource library for HCPs, and patient videos that highlight diagnoses, patient journeys, and the impact on their lives.

Bionical Solutions is able to layer artificial intelligence technology into KOL Select, providing HCP engagement data that informs topics for future interactions between brand advocates and valued stakeholders. In addition to providing unique engagement opportunities for pharmaceutical sales reps, included in the experience is a robust analytics and insights dashboard, facilitating Bionical Solutions’ customers to view valuable data on chosen education topics and call-to-action choices within their customers base—nationally, locally, and down to the district level.

As part of the company’s commitment to continuous growth and improvement, the proprietary KOL Select platforms benefit from close collaboration and vision with Bionical’s in-house teams of medical experts, behavioral psychologists, designers, and user experience leaders and digital developers—supporting R&D, Medical Affairs, and Marketing teams domestically and globally.

The KOL Select platform is uniquely positioned to help brands achieve a range of strategic imperatives built for continuous innovation to better meet clients’ emerging needs, complexities in therapeutic decisions, and patients taking a greater role in managing their own health.


You May Also Like

Movers and Shakers January/February 2022

Fingerpaint Names New Global President The global commercialization partner for the biopharma industry appointed ...

PM360 2021 Innovative Company Sharecare

Sharecare Laura Klein, EVP & GM, Consumer Solutions Sharecare has been developing and ...